药物研发-话题@MedSci

#药物研发#

120篇内容 | 3832人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301481, encodeId=222c130148183, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Nat Commun：揭秘唐氏综合症患者记忆与认知障碍关键机制，药物研发有望成功！, objectType=article, longId=182423, objectId=2f0618242318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f0618242318, replyNumber=0, likeNumber=98, createdTime=2019-11-07, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f0618242318, moduleTitle=Nat Commun：揭秘唐氏综合症患者记忆与认知障碍关键机制，药物研发有望成功！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f0618242318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301480, encodeId=a33c1301480ee, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨！, objectType=article, longId=182177, objectId=f15b1821e7b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15b1821e7b4, replyNumber=0, likeNumber=64, createdTime=2019-11-01, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15b1821e7b4, moduleTitle=Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15b1821e7b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301479, encodeId=268d13014e947, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨, objectType=article, longId=182142, objectId=a050182142c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a050182142c9, replyNumber=0, likeNumber=79, createdTime=2019-10-31, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a050182142c9, moduleTitle=Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a050182142c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301478, encodeId=15e113014e8a8, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, objectType=article, longId=181293, objectId=b6141812936b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6141812936b, replyNumber=0, likeNumber=71, createdTime=2019-10-17, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6141812936b, moduleTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6141812936b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301477, encodeId=5a8213014e7e1, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=一文读懂中国抗抑郁药物研发进展, objectType=article, longId=181260, objectId=bb75181260ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb75181260ec, replyNumber=0, likeNumber=109, createdTime=2019-10-17, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb75181260ec, moduleTitle=一文读懂中国抗抑郁药物研发进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb75181260ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301476, encodeId=6dcc13014e6d9, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, objectType=article, longId=181179, objectId=d68a1811e971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d68a1811e971, replyNumber=0, likeNumber=70, createdTime=2019-10-16, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d68a1811e971, moduleTitle=2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d68a1811e971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301475, encodeId=b90413014e5ce, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, objectType=article, longId=180747, objectId=9a2a180e47c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2a180e47c8, replyNumber=0, likeNumber=79, createdTime=2019-10-10, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2a180e47c8, moduleTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2a180e47c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301474, encodeId=2de413014e414, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=就差临门一脚？现在说AI药物研发时代到来还为时尚早, objectType=article, longId=179393, objectId=78841e939351, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78841e939351, replyNumber=0, likeNumber=60, createdTime=2019-09-15, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78841e939351, moduleTitle=就差临门一脚？现在说AI药物研发时代到来还为时尚早, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78841e939351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301473, encodeId=8ff313014e3bc, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=AI药物研发公司B轮融3700万美元，9月自然子刊发文, objectType=article, longId=179275, objectId=2a1d1e9275b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a1d1e9275b6, replyNumber=0, likeNumber=98, createdTime=2019-09-12, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a1d1e9275b6, moduleTitle=AI药物研发公司B轮融3700万美元，9月自然子刊发文, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a1d1e9275b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301472, encodeId=146f13014e210, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎, objectType=article, longId=176265, objectId=35521e626537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35521e626537, replyNumber=0, likeNumber=67, createdTime=2019-07-28, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35521e626537, moduleTitle=中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35521e626537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301471, encodeId=d4c513014e19a, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=《科学美国人》发布2019年全球十大新兴技术，药物研发新靶点上榜, objectType=article, longId=174807, objectId=7ed91e48070e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ed91e48070e, replyNumber=0, likeNumber=51, createdTime=2019-07-06, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ed91e48070e, moduleTitle=《科学美国人》发布2019年全球十大新兴技术，药物研发新靶点上榜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ed91e48070e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301470, encodeId=52d213014e013, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=CDE发布《真实世界证据支持药物研发的基本考虑》意见稿, objectType=article, longId=167225, objectId=6b6b16e2253b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b6b16e2253b, replyNumber=0, likeNumber=82, createdTime=2019-06-01, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b6b16e2253b, moduleTitle=CDE发布《真实世界证据支持药物研发的基本考虑》意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b6b16e2253b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301469, encodeId=24f91301469f0, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=真实世界证据支持药物研发的基本考虑（征求意见稿）, objectType=article, longId=167166, objectId=13bf16e16607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13bf16e16607, replyNumber=0, likeNumber=66, createdTime=2019-05-31, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13bf16e16607, moduleTitle=真实世界证据支持药物研发的基本考虑（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13bf16e16607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301468, encodeId=6980130146845, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=CDE：《真实世界证据支持药物研发的基本考虑》意见稿, objectType=article, longId=167147, objectId=6ff616e1473e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ff616e1473e, replyNumber=0, likeNumber=0, createdTime=2019-05-31, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ff616e1473e, moduleTitle=CDE：《真实世界证据支持药物研发的基本考虑》意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ff616e1473e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301467, encodeId=9c3d130146ed6, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=4+7带量采购背后，加速药物研发效率是关键, objectType=article, longId=166437, objectId=13df16643e29, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13df16643e29, replyNumber=0, likeNumber=55, createdTime=2019-05-22, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13df16643e29, moduleTitle=4+7带量采购背后，加速药物研发效率是关键, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13df16643e29)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301466, encodeId=d92d130146619, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟, objectType=article, longId=166331, objectId=b5b416633140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5b416633140, replyNumber=0, likeNumber=84, createdTime=2019-05-20, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5b416633140, moduleTitle=Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5b416633140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301465, encodeId=dee01301465fa, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=2019：全球乙肝药物研发管线（HBV Pipeline）, objectType=article, longId=166159, objectId=b890166159f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b890166159f4, replyNumber=0, likeNumber=75, createdTime=2019-05-17, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b890166159f4, moduleTitle=2019：全球乙肝药物研发管线（HBV Pipeline）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b890166159f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301464, encodeId=70671301464fd, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Lancet Oncol：张力、沈琳教授等在Lancet子刊刊文，我国抗癌药物研发是喜是忧？, objectType=article, longId=160196, objectId=85c816019631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85c816019631, replyNumber=0, likeNumber=97, createdTime=2019-02-18, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85c816019631, moduleTitle=Lancet Oncol：张力、沈琳教授等在Lancet子刊刊文，我国抗癌药物研发是喜是忧？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85c816019631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301463, encodeId=fac5130146323, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=Lancet Oncol：张力教授领衔——中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告, objectType=article, longId=159648, objectId=e51715964873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e51715964873, replyNumber=0, likeNumber=36, createdTime=2019-02-09, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e51715964873, moduleTitle=Lancet Oncol：张力教授领衔——中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e51715964873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301462, encodeId=50ea130146232, content=<a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a>, objectTitle=【开年大吉】张力教授领衔在《柳叶刀》杂志发表《中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告》, objectType=article, longId=159598, objectId=808b1595986f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=808b1595986f, replyNumber=0, likeNumber=29, createdTime=2019-02-09, rootId=0, userName=huirong, userId=a435298, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=808b1595986f, moduleTitle=【开年大吉】张力教授领衔在《柳叶刀》杂志发表《中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=808b1595986f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药物研发

2020-05-29

huirong (审核中...)

前往app查看评论内容

#药物研发#

Nat Commun：揭秘唐氏综合症患者记忆与认知障碍关键机制，药物研发有望成功！

2019-11-07

huirong (审核中...)

前往app查看评论内容

#药物研发#

Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨！

2019-11-01

huirong (审核中...)

前往app查看评论内容

#药物研发#

Nat Mater：揭秘癌细胞扩散转移核心机制，相关药物研发也步入正轨

2019-10-31

huirong (审核中...)

前往app查看评论内容

#药物研发#

2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”

2019-10-17

huirong (审核中...)

前往app查看评论内容

#药物研发#

一文读懂中国抗抑郁药物研发进展

2019-10-17

huirong (审核中...)

前往app查看评论内容

#药物研发#

2019 CSCO 大咖发声：国内自主研发抗肿瘤药物研发“全面开花”

2019-10-16

huirong (审核中...)

前往app查看评论内容

#药物研发#

真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示

2019-10-10

huirong (审核中...)

前往app查看评论内容

#药物研发#

就差临门一脚？现在说AI药物研发时代到来还为时尚早

2019-09-15

huirong (审核中...)

前往app查看评论内容

#药物研发#

AI药物研发公司B轮融3700万美元，9月自然子刊发文

2019-09-12

huirong (审核中...)

前往app查看评论内容

#药物研发#

中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎

2019-07-28

huirong (审核中...)

前往app查看评论内容

#药物研发#

《科学美国人》发布2019年全球十大新兴技术，药物研发新靶点上榜

2019-07-06

huirong (审核中...)

前往app查看评论内容

#药物研发#

CDE发布《真实世界证据支持药物研发的基本考虑》意见稿

2019-06-01

huirong (审核中...)

前往app查看评论内容

#药物研发#

真实世界证据支持药物研发的基本考虑（征求意见稿）

2019-05-31

huirong (审核中...)

前往app查看评论内容

#药物研发#

CDE：《真实世界证据支持药物研发的基本考虑》意见稿

2019-05-31

huirong (审核中...)

前往app查看评论内容

#药物研发#

4+7带量采购背后，加速药物研发效率是关键

2019-05-22

huirong (审核中...)

前往app查看评论内容

#药物研发#

Genentech与Parvus结成了8亿美元的自身免疫性疾病药物研发联盟

2019-05-20

huirong (审核中...)

前往app查看评论内容

#药物研发#

2019：全球乙肝药物研发管线（HBV Pipeline）

2019-05-17

huirong (审核中...)

前往app查看评论内容

#药物研发#

Lancet Oncol：张力、沈琳教授等在Lancet子刊刊文，我国抗癌药物研发是喜是忧？

2019-02-18

huirong (审核中...)

前往app查看评论内容

#药物研发#

Lancet Oncol：张力教授领衔——中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告

2019-02-09

huirong (审核中...)

前往app查看评论内容

#药物研发#

【开年大吉】张力教授领衔在《柳叶刀》杂志发表《中国抗肿瘤药物研发的挑战与改变：肿瘤学I期临床试验年度报告》

2019-02-09

科室
- - 订阅+
  - 更多科室
工具
服务